| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/10/2003 | EP1368002A2 Method for producing a floating tablet containing alfuzosine |
| 12/10/2003 | EP1368001A2 Pharmaceutical formulation comprising bicalutamide |
| 12/10/2003 | EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 12/10/2003 | EP1367999A2 Water soluble and palatable complexes |
| 12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 12/10/2003 | EP1367996A1 Sustained-release suspension of ceftiofur hydrochloride |
| 12/10/2003 | EP1367992A2 Topical composition comprising a functionally alkylating cosmetic bonding agent |
| 12/10/2003 | EP1367989A1 Use of a mixture designed to reduce secretion of sebum in a cosmetic or dermatological composition |
| 12/10/2003 | EP1367987A2 Use of active-ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and/or uv-b wavelength range(s), for producing cosmetic or dermatological preparations |
| 12/10/2003 | EP1367970A1 Alkyl aryl polyether alcohol polymers for improvement of nasal breathing |
| 12/10/2003 | EP1367891A1 Pharmaceutical composition containing aminoacetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals |
| 12/10/2003 | EP1367886A2 Scce modified transgenic mammals and their use as models of human disease |
| 12/10/2003 | EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 12/10/2003 | EP1289364B1 Stable gabapentin containing more than 2o ppm of chlorine ion |
| 12/10/2003 | EP1284263B1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents |
| 12/10/2003 | EP1276477B1 Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
| 12/10/2003 | EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 12/10/2003 | EP1200393B1 Oxime amides and hydrazone amides having fungicidal activity |
| 12/10/2003 | EP1189916B1 N-pyrazole a 2a receptor agonists |
| 12/10/2003 | EP1187829B1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 12/10/2003 | EP1185276B1 Isophosphoramide mustard analogs and use thereof |
| 12/10/2003 | EP1177191B1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 12/10/2003 | EP1163243B1 Calanolides for inhibiting btk |
| 12/10/2003 | EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 12/10/2003 | EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa |
| 12/10/2003 | EP1144420B1 Sulfated phosphatidylinositols, their preparation and use |
| 12/10/2003 | EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules |
| 12/10/2003 | EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety |
| 12/10/2003 | EP1115721B1 Pyrimidone derivatives |
| 12/10/2003 | EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 12/10/2003 | EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases |
| 12/10/2003 | EP1077992B1 Use of meiosis regulating compounds |
| 12/10/2003 | EP1058687B1 Nucleosides |
| 12/10/2003 | EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 12/10/2003 | EP1039916B1 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies |
| 12/10/2003 | EP1017365B1 Liposome-entrapped polynucleotide composition and method |
| 12/10/2003 | EP0971885B1 Process for preparing indane-like compounds |
| 12/10/2003 | EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 12/10/2003 | EP0966276B1 Use of beta-3 adrenergic receptor agonists for preparing wound-healing pharmaceuticals |
| 12/10/2003 | EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 12/10/2003 | EP0935598B1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 12/10/2003 | EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS |
| 12/10/2003 | EP0904060B1 Antifungal compositions with improved bioavailability |
| 12/10/2003 | EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 12/10/2003 | EP0893995B1 Anticachectic composition |
| 12/10/2003 | EP0883400B1 Delivery system for localized administration of medicaments to the upper respiratory tract |
| 12/10/2003 | EP0853615B1 Piperidine compounds as calcium channel blockers |
| 12/10/2003 | EP0828498B1 Chemotherapeutic compositions |
| 12/10/2003 | EP0825867B1 N,o-carboxymethylchitosan for prevention of surgical adhesions |
| 12/10/2003 | EP0795560B1 Keratan sulfate oligosaccharide fraction and drug containing the same |
| 12/10/2003 | EP0778770B1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer |
| 12/10/2003 | EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives |
| 12/10/2003 | EP0711169B1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/10/2003 | EP0680316B1 Novel parasitic helminth proteins |
| 12/10/2003 | EP0671924B1 Digitalis-like compounds |
| 12/10/2003 | EP0666914B1 Novel p-selectin ligand protein |
| 12/10/2003 | EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 12/10/2003 | CN1461343A 多核苷酸 Polynucleotide |
| 12/10/2003 | CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B |
| 12/10/2003 | CN1461306A Thiazole Derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides |
| 12/10/2003 | CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 12/10/2003 | CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 12/10/2003 | CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 12/10/2003 | CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 12/10/2003 | CN1461222A Behavior chemotherapy |
| 12/10/2003 | CN1461219A Non-sedating barbiturate compounds as neuroprotective agents |
| 12/10/2003 | CN1461218A Therapeutic combination of amlodipine and benazepril |
| 12/10/2003 | CN1461217A Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders |
| 12/10/2003 | CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction |
| 12/10/2003 | CN1461214A Compositions for improving skin environment and clothes thereof |
| 12/10/2003 | CN1461213A 1-amino-alkylcyclohexanes as trypanocidal agents |
| 12/10/2003 | CN1461212A Hydrogel-driven drug dosage form |
| 12/10/2003 | CN1461211A Microparticles for pulmonary administation |
| 12/10/2003 | CN1461209A Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth |
| 12/10/2003 | CN1461207A Vaginal delivery of bisphosphonates |
| 12/10/2003 | CN1461188A Material for inproving living environment, and building material, laying material and spraying agent using the same |
| 12/10/2003 | CN1460684A Epimedium extract and its production method |
| 12/10/2003 | CN1460667A Pineapplie leaf extract, its preparation method and application |
| 12/10/2003 | CN1460500A Fragrance body health-care product |
| 12/10/2003 | CN1460485A New process for making animal medicine madumycin ammonium, ivermection or dikezhuli premixed agent |
| 12/10/2003 | CN1460484A Bacillus prodigiosus polysaccharide for nose drops |
| 12/10/2003 | CN1460483A Medicine for curing cerebrovascular diseases and its preparation method |
| 12/10/2003 | CN1460482A Medicine composite containing icaritin and demethylicaritin and its application |
| 12/10/2003 | CN1460481A Medicine composition using resveratrol glucodside for curing fatty liver and its preparation method |
| 12/10/2003 | CN1460480A Hypoglycemic health-care food for diabetes type Ôàí" |
| 12/10/2003 | CN1460479A New application of lactose derivative |
| 12/10/2003 | CN1460478A Huangyangning slow-releasing preparation |
| 12/10/2003 | CN1460477A Prpearation method of H2 receptor antagonist composite salt and its application |
| 12/10/2003 | CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate |
| 12/10/2003 | CN1460475A Sophoridine soft capsule for curing malignant tumor and its preparation method |
| 12/10/2003 | CN1460474A Application of geldanamycin in preparation of medicine for curing SARS |
| 12/10/2003 | CN1460473A Application of brataxin in preparation of medicine for inhibiting AIDS virus |
| 12/10/2003 | CN1460472A Biquanide vanadium complex plaster preparation for curing diabetes and its application |
| 12/10/2003 | CN1460471A Fenofibrate soft capsule and its preparation method |
| 12/10/2003 | CN1460470A Dichlofenac sodium slow-releasing preparation and its preparation method |
| 12/10/2003 | CN1460469A Preparation method of aspirin microsphere |
| 12/10/2003 | CN1460467A Adriamycin liposome hydrochloride for injection |
| 12/10/2003 | CN1130459C Biological active molecules having potentiating effect on growth hormone biological activity |
| 12/10/2003 | CN1130372C 肽衍生物 Peptide derivatives |
| 12/10/2003 | CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use |